Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

3-Morpholinosydnonimine (CAS 16142-27-1)

5.0(1)
Write a reviewAsk a question

See product citations (10)

Alternate Names:
3-Morpholinosydnonimine is also known as SIN-1.
Application:
3-Morpholinosydnonimine is a potent vasodilator that inhibits platelet aggregation and cysteine proteases.
CAS Number:
16142-27-1
Purity:
≥98%
Molecular Weight:
206.63
Molecular Formula:
C6H10N4O2•HCl
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

3-Morpholinosydnonimine (SIN-1) is a metabolite of molsidomine (sc-200337) which may act to decompose spontaneously in solution in the presence of oxygen. This reaction with 3-Morpholinosydnonimine releases nitric oxide (NO) and a superoxide anion, which under physiological conditions, reacts to produce peroxynitrite. 3-Morpholinosydnonimine is a potent vasodilator, inhibitor of platelet aggregation, general cysteine protease inhibitor. 3-Morpholinosydnonimine may act to produce significant protective effects in myocardial ischemia-reperfusion. Some of the effects of 3-Morpholinosydnonimine can be attenuated by nitroglycerin-induced tolerance.


3-Morpholinosydnonimine (CAS 16142-27-1) References

  1. Inhibition of cysteine protease activity by NO-donors.  |  Ascenzi, P., et al. 2001. Curr Protein Pept Sci. 2: 137-53. PMID: 12370021
  2. Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons.  |  Sharma, SK. and Ebadi, M. 2003. Antioxid Redox Signal. 5: 251-64. PMID: 12880480
  3. Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide.  |  Hogg, N., et al. 1992. Biochem J. 281 (Pt 2): 419-24. PMID: 1310595
  4. Protective effect of 1-methylated beta-carbolines against 3-morpholinosydnonimine-induced mitochondrial damage and cell viability loss in PC12 cells.  |  Choi, WT., et al. 2004. Neurochem Res. 29: 1807-16. PMID: 15532535
  5. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion.  |  Siegfried, MR., et al. 1992. J Pharmacol Exp Ther. 260: 668-75. PMID: 1738117
  6. The peroxynitrite donor 3-morpholinosydnonimine induces reversible changes in electrophysiological properties of neurons of the guinea-pig spinal cord.  |  Ashki, N., et al. 2008. Neuroscience. 156: 107-17. PMID: 18662749
  7. 3-morpholinosydnonimine participates in the attenuation of neointima formation via inhibition of annexin A2-mediated vascular smooth muscle cell migration.  |  Won, KJ., et al. 2011. Proteomics. 11: 193-201. PMID: 21204247
  8. The peroxynitrite donor 3-morpholinosydnonimine activates Nrf2 and the UPR leading to a cytoprotective response in endothelial cells.  |  Mattart, L., et al. 2012. Cell Signal. 24: 199-213. PMID: 21945407
  9. Nitroglycerin-induced tolerance affects multiple sites in the organic nitrate bioconversion cascade.  |  Henry, PJ., et al. 1989. J Pharmacol Exp Ther. 248: 762-8. PMID: 2563771
  10. 3-morpholinosydnonimine (SIN-1)-induced oxidative stress leads to necrosis in hypertrophic chondrocytes in vitro.  |  He, Y., et al. 2018. Biomed Pharmacother. 106: 1696-1704. PMID: 30119244
  11. Inhibition of platelet aggregation and stimulation of guanylate cyclase by an antianginal agent molsidomine and its metabolites.  |  Nishikawa, M., et al. 1982. J Pharmacol Exp Ther. 220: 183-90. PMID: 6118429
  12. Increased cytotoxicity of 3-morpholinosydnonimine to HepG2 cells in the presence of superoxide dismutase. Role of hydrogen peroxide and iron.  |  Gergel, D., et al. 1995. J Biol Chem. 270: 20922-9. PMID: 7673115
  13. Spin-trapping studies of peroxynitrite decomposition and of 3-morpholinosydnonimine N-ethylcarbamide autooxidation: direct evidence for metal-independent formation of free radical intermediates.  |  Augusto, O., et al. 1994. Arch Biochem Biophys. 310: 118-25. PMID: 8161194
  14. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds.  |  Lipton, SA., et al. 1993. Nature. 364: 626-32. PMID: 8394509
  15. Activation of soluble guanylyl cyclase by the nitrovasodilator 3-morpholinosydnonimine involves formation of S-nitrosoglutathione.  |  Schrammel, A., et al. 1998. Mol Pharmacol. 54: 207-12. PMID: 9658207

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

3-Morpholinosydnonimine, 20 mg

sc-200339
20 mg
$89.00

3-Morpholinosydnonimine, 100 mg

sc-200339A
100 mg
$369.00

What is the half life of this chemical?

Asked by: Io5ay
Thank you for your question. We have not determined the half life of 3-morpholinosydnonimine, hydrochloride (SIN-1), BML-CN245. As per an article in Clinical Pharmokinetics, the half life of BML-CN245-0020 is 1- 2 hour.
Answered by: Technical Support
Date published: 2017-03-09

Can solutions be prepared in advance or should they be prepared prior to use?

Asked by: Io5ay
Thank you for your question. We recommend dissolving the product freshly each time before use.
Answered by: Technical Support
Date published: 2017-03-09

What is the stability of this compound in water?

Asked by: Io5ay
Thank you for your question. This compound is soluble in water to 100 mM and in DMSO to 10 mM. The product can be stored for up to 12 months, providing storage is as stated on the product vial and the vial is kept tightly sealed. Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Answered by: Technical Support
Date published: 2017-03-09
  • y_2026, m_4, d_23, h_7CST
  • bvseo_bulk, prod_bvqa, vn_bulk_3.0.43
  • cp_1, bvpage1
  • co_hasquestionsanswers, tq_3
  • loc_en_US, sid_200339, prod, sort_[SortEntry(order=LAST_APPROVED_ANSWER_SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getContent, 109ms
  • QUESTIONS, PRODUCT
Rated 5 out of 5 by from Kang et alKang et al. (PubMed ID 14742271) used 3-Morpholinosydnonimine (SIN-1) to generate nitric oxide and found this to inhibit VEGF expression in rat proximal tubule (NRK52E) cells.
Date published: 2015-06-10
  • y_2026, m_4, d_23, h_7
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.43
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_200339, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getReviews, 19ms
  • REVIEWS, PRODUCT
3-Morpholinosydnonimine is rated 5.0 out of 5 by 1.
  • y_2026, m_4, d_23, h_7
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.43
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_200339, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getAggregateRating, 118ms
  • REVIEWS, PRODUCT